Altris.AI

About:

FDA-cleared AI-powered ophthalmic image management system that detects 70+ retina pathologies and biomarkers on OCT scans.

Website: https://www.altris.ai/

Twitter/X: Altris_AI

Top Investors: Brinc, Artesian VC, Farmak, Runa Capital, The University of Chicago Booth School of Business

Description:

Altris.AI is a MedTech company that uses AI to set higher diagnostics standards and improve patient outcomes as a result. Altris AI uses the most extensive dataset of ophthalmic images and an advanced algorithm that recognizes 70+ retina pathologies and biomarkers on OCT scans.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2017-04-12

Contact Email:

info(AT)altris.ai

Founders:

Andrey Kuropyatnyk, Anton Velychko, Maria Znamenska

Number of Employees:

11-50

Last Funding Date:

2023-08-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai